发明申请
US20110009405A1 PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY
有权
吡嗪二酮和1,3,5-三嗪基苯并咪唑及其在癌症治疗中的应用
- 专利标题： PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY
- 专利标题（中）： 吡嗪二酮和1,3,5-三嗪基苯并咪唑及其在癌症治疗中的应用
-
申请号： US12831128申请日： 2010-07-06
-
公开(公告)号： US20110009405A1公开(公告)日： 2011-01-13
- 发明人: Gordon William Rewcastle , Kit Yee Tsang , Swarnalatha Akuratiya Gamage , Anna Claire Giddens
- 申请人： Gordon William Rewcastle , Kit Yee Tsang , Swarnalatha Akuratiya Gamage , Anna Claire Giddens
- 申请人地址： NZ Auckland
- 专利权人： Pathway Therapeutics Limited
- 当前专利权人： Pathway Therapeutics Limited
- 当前专利权人地址： NZ Auckland
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D413/14 ; A61P35/00 ; C12N9/12
摘要：
Provided herein are pyrimidinyl and 1,3,5-triazinyl benzimidazoles of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for cancer therapy, either alone or in combination with radiation and/or other anticancer drugs.
公开/授权文献
信息查询
IPC分类:
